These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20443777)

  • 1. Metal-containing drugs and novel coordination complexes in therapeutic anticancer applications--Part I. Editorial.
    Kostova I
    Anticancer Agents Med Chem; 2010 May; 10(4):270-1. PubMed ID: 20443777
    [No Abstract]   [Full Text] [Related]  

  • 2. Metal-containing drugs and novel coordination complexes in therapeutic anticancer applications--part II.
    Kostova I
    Anticancer Agents Med Chem; 2010 Jun; 10(5):352-3. PubMed ID: 20545617
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Anticancer Ruthenium Complexes in Drug Discovery and Medicinal Chemistry.
    Thota S
    Mini Rev Med Chem; 2016; 16(10):771. PubMed ID: 27161007
    [No Abstract]   [Full Text] [Related]  

  • 4. Metal complexes in medicine and pharmacy - the past and the present II.
    Habala L; Valentová J
    Ceska Slov Farm; 2020; 69(1):3-16. PubMed ID: 32460505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent metal-based complexes as cancer probes.
    de Almeida A; Bonsignore R
    Bioorg Med Chem Lett; 2020 Jul; 30(13):127219. PubMed ID: 32360103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent development of transition metal complexes with in vivo antitumor activity.
    Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
    J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent researches in metal supramolecular complexes as anticancer agents.
    Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
    Anticancer Agents Med Chem; 2010 Jun; 10(5):371-95. PubMed ID: 20380632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The progresses in curcuminoids-based metal complexes: especially in cancer therapy.
    Zhang Y; Khan AR; Fu M; Zhai Y; Yu A; Zhai G
    Future Med Chem; 2019 May; 11(9):1035-1056. PubMed ID: 31140861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
    Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M
    Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trapping unstable benzoquinone analogues by coordination to a [(η(5)-C(5)Me(5))Ir] fragment and the anticancer activity of the resulting complexes.
    Hartinger CG
    Angew Chem Int Ed Engl; 2010 Nov; 49(45):8304-5. PubMed ID: 20803595
    [No Abstract]   [Full Text] [Related]  

  • 12. Unveiling the Potential of Transition Metal Complexes for Medicine: Translational in Situ Activation of Metal-Based Drugs from Bench to in Vivo Applications.
    Silva MJSA; Gois PMP; Gasser G
    Chembiochem; 2021 May; 22(10):1740-1742. PubMed ID: 33507625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer metallodrugs: where is the next cisplatin?
    Hanif M; Hartinger CG
    Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organometallic anticancer compounds.
    Gasser G; Ott I; Metzler-Nolte N
    J Med Chem; 2011 Jan; 54(1):3-25. PubMed ID: 21077686
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticancer metallotherapeutics in preclinical development.
    Kaluderović GN; Paschke R
    Curr Med Chem; 2011; 18(31):4738-52. PubMed ID: 21919843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of Resonant X-ray Emission Spectroscopy (RXES) for the electronic analysis of metal complexes and their interactions with biomolecules.
    Sá J; Czapla-Masztafiak J; Lipiec E; Kayser Y; Kwiatek W; Wood B; Deacon GB; Berger G; Dufrasne F; Fernandes DL; Szlachetko J
    Drug Discov Today Technol; 2015 Sep; 16():1-6. PubMed ID: 26547415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallo-organic G-quadruplex ligands in anticancer drug design.
    Jiang YL; Liu ZP
    Mini Rev Med Chem; 2010 Jul; 10(8):726-36. PubMed ID: 20412042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential photoactivated metallopharmaceuticals: from active molecules to supported drugs.
    Crespy D; Landfester K; Schubert US; Schiller A
    Chem Commun (Camb); 2010 Sep; 46(36):6651-62. PubMed ID: 20717579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in copper complexes as anticancer agents.
    Santini C; Pellei M; Gandin V; Porchia M; Tisato F; Marzano C
    Chem Rev; 2014 Jan; 114(1):815-62. PubMed ID: 24102434
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
    Zhang Z; Wang H; Yan M; Wang H; Zhang C
    Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.